Eli Lilly boss brands UK ‘worst country in Europe’ for cheap drug prices
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more
Dave Ricks says Britain will miss out on medicines and future investment unless it pays more
US drugmaker wants changes to types of drugs approved in Britain
US pharmaceutical group ‘optimistic’ about reaching deal with British government
Accord will result in higher medicines spending in Britain in exchange for exemption from threatened Trump tariffs
Ambassador’s meeting with chancellor Rachel Reeves came days before AstraZeneca and Merck paused projects in Britain
Life sciences should be a natural place to look for growth
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines
